Zurcher Kantonalbank (Zurich Cantonalbank) Oric Pharmaceuticals, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $33.8 Billion
- Q1 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 12,626 shares of ORIC stock, worth $66,791. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,626
Previous 14,176
10.93%
Holding current value
$66,791
Previous $114,000
38.6%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ORIC
# of Institutions
144Shares Held
75.9MCall Options Held
11.3KPut Options Held
2.7K-
Viking Global Investors LP6.57MShares$34.8 Million0.12% of portfolio
-
Nextech Invest Ag5.29MShares$28 Million7.95% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.29MShares$28 Million6.85% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$25.6 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY4MShares$21.2 Million0.05% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $209M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...